irdabisant (CEP-26401)
/ Teva
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 04, 2019
Central nervous system effects of the histamine-3 receptor antagonist CEP-26401, in comparison with modafinil and donepezil, after a single dose in a cross-over study in healthy volunteers.
(PubMed, Br J Clin Pharmacol)
- "Of the doses tested, the 25 μg dose of CEP-26401 had the most optimal balance between favourable subjective effects and sleep inhibition. Whether CEP-26401 can have beneficial effects in clinical practice remains to be studied."
Clinical • Journal
1 to 1
Of
1
Go to page
1